Stock Track | Tempus AI Soars 5.04% Intraday on Positive ALERT Trial Results Showing AI EHR Alerts Improve Heart Disease Treatment

Stock Track04-01 21:48

Tempus AI's stock surged 5.04% during intraday trading following the announcement of positive results from its ALERT trial in collaboration with Medtronic.

The study, which was presented at the American College of Cardiology's 75th Annual Scientific Session, met its primary endpoint, demonstrating that automated AI-driven notifications in electronic health records were superior to usual care in a win ratio analysis. The trial specifically showed that these AI EHR alerts improved timely evaluation and treatment for patients with significant aortic stenosis or mitral regurgitation.

Further details from the trial indicated that the EHR-integrated decision support could help narrow undertreatment disparities by standardizing follow-up for high-risk findings across different patient groups. One report highlighted that the AI alerts lifted valve interventions by 40%, representing a significant improvement in patient care outcomes.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1181831107?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-01 21:48","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1181831107","market":"sg","top_or_hot":-1,"title":"Stock Track | Tempus AI Soars 5.04% Intraday on Positive ALERT Trial Results Showing AI EHR Alerts Improve Heart Disease Treatment","media":"Stock Track","content":"<p>Tempus AI's stock surged 5.04% during intraday trading following the announcement of positive results from its ALERT trial in collaboration with Medtronic.</p><p>The study, which was presented at the American College of Cardiology's 75th Annual Scientific Session, met its primary endpoint, demonstrating that automated AI-driven notifications in electronic health records were superior to usual care in a win ratio analysis. The trial specifically showed that these AI EHR alerts improved timely evaluation and treatment for patients with significant aortic stenosis or mitral regurgitation.</p><p>Further details from the trial indicated that the EHR-integrated decision support could help narrow undertreatment disparities by standardizing follow-up for high-risk findings across different patient groups. One report highlighted that the AI alerts lifted valve interventions by 40%, representing a significant improvement in patient care outcomes.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Tempus AI Soars 5.04% Intraday on Positive ALERT Trial Results Showing AI EHR Alerts Improve Heart Disease Treatment</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Tempus AI Soars 5.04% Intraday on Positive ALERT Trial Results Showing AI EHR Alerts Improve Heart Disease Treatment\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-04-01 21:48</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Tempus AI's stock surged 5.04% during intraday trading following the announcement of positive results from its ALERT trial in collaboration with Medtronic.</p><p>The study, which was presented at the American College of Cardiology's 75th Annual Scientific Session, met its primary endpoint, demonstrating that automated AI-driven notifications in electronic health records were superior to usual care in a win ratio analysis. The trial specifically showed that these AI EHR alerts improved timely evaluation and treatment for patients with significant aortic stenosis or mitral regurgitation.</p><p>Further details from the trial indicated that the EHR-integrated decision support could help narrow undertreatment disparities by standardizing follow-up for high-risk findings across different patient groups. One report highlighted that the AI alerts lifted valve interventions by 40%, representing a significant improvement in patient care outcomes.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TEM","symbol_name":"Tempus AI","start_time":0,"source_url":"","article_id":"1181831107","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1181831107","pubTimestamp":1775051297,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Tempus AI's stock surged 5.04% during intraday trading following the announcement of positive results from its ALERT trial in collaboration with Medtronic.The study, which was presented at the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TEM":"Tempus AI"},"translate_title":"个股追踪|腾邦AI盘中飙升5.04%，利好警报试验结果显示AI EHR警报改善心脏病治疗","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TEM":1},"content_text":"Tempus AI's stock surged 5.04% during intraday trading following the announcement of positive results from its ALERT trial in collaboration with Medtronic.The study, which was presented at the American College of Cardiology's 75th Annual Scientific Session, met its primary endpoint, demonstrating that automated AI-driven notifications in electronic health records were superior to usual care in a win ratio analysis. The trial specifically showed that these AI EHR alerts improved timely evaluation and treatment for patients with significant aortic stenosis or mitral regurgitation.Further details from the trial indicated that the EHR-integrated decision support could help narrow undertreatment disparities by standardizing follow-up for high-risk findings across different patient groups. One report highlighted that the AI alerts lifted valve interventions by 40%, representing a significant improvement in patient care outcomes.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1181831107","isCrawlerRequest":true}